Check it out, and get in touch if you have any questions!
Mandatory Information:
BELKYRA® injection is a prescription medicine containing 10 mg/mL deoxycholic acid.
It is used for the improvement in the appearance of moderate to severe convexity or fullness
associated with fat below the jaws in adults.
Do not use in people allergic to this medicine, with infection at site of injection,
pregnancy, and lactation.
Possible side effects include headaches, difficulty swallowing, nausea, skin tightness,
hypertension, injection site bruising, pain, swelling, numbness, redness, tingling,
hardness, itching, discolouration, warmth, and injection site nerve injury.
BELKYRA® treatment is not funded on the New Zealand Pharmaceutical Schedule.
You will need to pay for this medicine. Normal doctor visit fees apply.
Treatment should be administered only by trained medical professionals.
Speak to your specialist about your own situation and the benefits/risks of this procedure.
For further information, the Data Sheet and Consumer Medicines Information can be accessed at www.medsafe.govt.nz.
If you have any side effects or concerns, speak to your doctor.
Results from BELKYRA® treatment usually last up to 4 years.
Allergan New Zealand Limited, Auckland.